Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense
Authors
Keywords
-
Journal
ARCHIVES OF PHARMACAL RESEARCH
Volume 35, Issue 8, Pages 1297-1316
Publisher
Springer Nature
Online
2012-09-02
DOI
10.1007/s12272-012-0802-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion
- (2012) Huan Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer
- (2011) B. Salaun et al. CANCER RESEARCH
- Activation of Toll-like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth
- (2011) Z. Cai et al. CANCER RESEARCH
- Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?
- (2011) Li Yu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
- (2011) H. Lu et al. CLINICAL CANCER RESEARCH
- Toll-like receptor modulators: a patent review (2006 – 2010)
- (2011) Shaherin Basith et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk
- (2011) Anton G. Kutikhin HUMAN IMMUNOLOGY
- Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial
- (2011) Charles Butts et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma
- (2011) Hanna Ronkainen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Increased Expression of Toll-like Receptors (TLR) 2, 4 and 5 in Gastric Dysplasia
- (2011) Pedro Pimentel-Nunes et al. PATHOLOGY & ONCOLOGY RESEARCH
- Alteration of CXCR7 Expression Mediated by TLR4 Promotes Tumor Cell Proliferation and Migration in Human Colorectal Carcinoma
- (2011) Huanbai Xu et al. PLoS One
- Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma
- (2011) Ilyar Sheyhidin WORLD JOURNAL OF GASTROENTEROLOGY
- Similar Structures but Different Roles – An Updated Perspective on TLR Structures
- (2011) Balachandran Manavalan et al. Frontiers in Physiology
- Expression and Functional Research of TLR4 in Human Colon Carcinoma
- (2010) Xiao-Yan Tang et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
- (2010) Salomé González-Reyes et al. BMC CANCER
- The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia
- (2010) Yasmin Hernandez et al. BMC GASTROENTEROLOGY
- Toll-like receptor 2 is present in the microenvironment of oral squamous cell carcinoma
- (2010) L K Ng et al. BRITISH JOURNAL OF CANCER
- TLR3 activation inhibits nasopharyngeal carcinoma metastasis via down-regulation of chemokine receptor CXCR4
- (2010) Yu Zhang et al. CANCER BIOLOGY & THERAPY
- Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
- (2010) Salomé González-Reyes et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
- (2010) C. Brignole et al. CANCER RESEARCH
- Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors
- (2010) Regina Berger et al. CANCER SCIENCE
- Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression
- (2010) Martin Grimm et al. EUROPEAN JOURNAL OF CANCER
- Abrogation of TLR4 and CD14 Expression and Signaling in Human Adrenocortical Tumors
- (2010) Waldemar Kanczkowski et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
- (2010) Julien Cherfils-Vicini et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Toll-Like Receptor 2 Signaling Protects Mice from Tumor Development in a Mouse Model of Colitis-Induced Cancer
- (2010) Emily L. Lowe et al. PLoS One
- Potential therapeutic interventions for fragile X syndrome
- (2010) Josien Levenga et al. TRENDS IN MOLECULAR MEDICINE
- Expression and significance of TLR4 and HIF-1α in pancreatic ductal adenocarcinoma
- (2010) Jian-Jun Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
- (2009) Jörg Vollmer et al. ADVANCED DRUG DELIVERY REVIEWS
- Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-κB-dependent activation of the urokinase plasminogen activator system
- (2009) S D Killeen et al. BRITISH JOURNAL OF CANCER
- Toll-like receptor expression in normal ovary and ovarian tumors
- (2009) Mingfu Zhou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Toll-like Receptors 3 and 7 Agonists Enhance Tumor Cell Lysis by Human T Cells
- (2009) H. Shojaei et al. CANCER RESEARCH
- Triggering of Toll-like Receptor 4 Expressed on Human Head and Neck Squamous Cell Carcinoma Promotes Tumor Development and Protects the Tumor from Immune Attack
- (2009) M. J. Szczepanski et al. CANCER RESEARCH
- Morphological study on Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105)
- (2009) Yuko Uenishi et al. JOURNAL OF MICROBIOLOGICAL METHODS
- A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia
- (2009) D E Spaner et al. LEUKEMIA
- Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity
- (2009) Dong Hua et al. MOLECULAR IMMUNOLOGY
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
- (2009) Sunhwa Kim et al. NATURE
- Unleashing the therapeutic potential of NOD-like receptors
- (2009) Kaoru Geddes et al. NATURE REVIEWS DRUG DISCOVERY
- TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer
- (2009) M Szajnik et al. ONCOGENE
- Functionally Active Toll-Like Receptor 3 on Human Primary and Metastatic Cancer Cells
- (2009) T. Matijevic et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway
- (2008) Qun Jiang et al. BMC CANCER
- Comparison of human B cell activation by TLR7 and TLR9 agonists
- (2008) John A Hanten et al. BMC IMMUNOLOGY
- Toll-like receptors expressed in tumor cells: targets for therapy
- (2008) Li Yu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors
- (2008) Masashi Murata CANCER SCIENCE
- Eradication of Ovarian Tumor Xenografts by Locoregional Administration of Targeted Immunotherapy
- (2008) M. De Cesare et al. CLINICAL CANCER RESEARCH
- An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma
- (2008) R. Dummer et al. CLINICAL CANCER RESEARCH
- Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer
- (2008) Sang Hoon Rhee et al. GASTROENTEROLOGY
- Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling
- (2008) Yigang Qian et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Increased expression of Toll-like receptors 4 and 9 in human lung cancer
- (2008) Yan-Bei Zhang et al. MOLECULAR BIOLOGY REPORTS
- Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors
- (2008) Y. Goto et al. MOLECULAR CANCER THERAPEUTICS
- Characterization of bovine Toll-like receptor 8: Ligand specificity, signaling essential sites and dimerization
- (2008) Jianzhong Zhu et al. MOLECULAR IMMUNOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β
- (2008) Jonathan C Kagan et al. NATURE IMMUNOLOGY
- Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
- (2008) A M Krieg ONCOGENE
- Cancers take their Toll—the function and regulation of Toll-like receptors in cancer cells
- (2008) R Chen et al. ONCOGENE
- TLR signaling by tumor and immune cells: a double-edged sword
- (2008) B Huang et al. ONCOGENE
- TLR7 and TLR8 as targets in cancer therapy
- (2008) M P Schön et al. ONCOGENE
- Polymorphisms in Toll-like receptor genes and risk of cancer
- (2008) E M El-Omar et al. ONCOGENE
- An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
- (2008) L. G. Burdelya et al. SCIENCE
- Role of neutrophils in BCG immunotherapy for bladder cancer
- (2008) Mark P. Simons et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Anti-tumor effect of DNA-based vaccination and dSLIM immunomodulatory molecules in mice with Ph+ acute lymphoblastic leukaemia
- (2008) Joachim Köchling et al. VACCINE
- Increased expression of Toll-like receptor 5 during progression of cervical neoplasia
- (2007) W.Y. KIM et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now